Avantor, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US05352A1007
USD
11.15
-0.14 (-1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.74 M

Shareholding (Mar 2025)

FII

28.13%

Held by 290 FIIs

DII

10.64%

Held by 139 DIIs

Promoter

2.11%

How big is Avantor, Inc.?

22-Jun-2025

As of Jun 18, Avantor, Inc. has a market capitalization of $8.96 billion, with net sales of $6.69 billion and a net profit of $715.6 million over the last four quarters.

As of Jun 18, Avantor, Inc. has a market capitalization of 8,960.80 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 6,685.20 million, while the sum of consolidated net profit for the same period is 715.60 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds amounting to 5,956.70 million and total assets of 12,114.50 million.

Read More

What does Avantor, Inc. do?

22-Jun-2025

Avantor, Inc. is a global provider of specialty chemicals and mission-critical products, with net sales of $1.58 billion and a market cap of approximately $8.96 billion as of March 2025. Key financial metrics include a P/E ratio of 11.00 and a return on equity of 12.74%.

Overview: <BR>Avantor, Inc. is a global provider of mission-critical products and services in the specialty chemicals industry, categorized as a mid-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 1,581 Million (Quarterly Results - Mar 2025) <BR>Net Profit: 64 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 8,960.80 Million (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.62 <BR>Return on Equity: 12.74% <BR>Price to Book: 1.47<BR><BR>Contact Details: <BR>Address: Building One, 100 W Matsonford Rd Ste 200 RADNOR PA : 19087 <BR>Tel: 1 610 3861700 <BR>Website: https://www.avantorsciences.com/

Read More

Who are in the management team of Avantor, Inc.?

22-Jun-2025

As of March 2022, Avantor, Inc.'s management team includes Chairman Rajiv Gupta, CEO Michael Stubblefield, and Directors Matthew Holt, Andre Moura, Jo Natauri, Juan Andres, and Jonathan Peacock. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Avantor, Inc. includes the following individuals:<BR><BR>- Mr. Rajiv Gupta, who serves as the Chairman of the Board.<BR>- Mr. Michael Stubblefield, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Matthew Holt, who is a Director.<BR>- Mr. Andre Moura, who is a Director.<BR>- Ms. Jo Natauri, who is a Director.<BR>- Mr. Juan Andres, who is an Independent Director.<BR>- Mr. Jonathan Peacock, who is also an Independent Director. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Read More

Is Avantor, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Avantor, Inc. is considered an attractive investment due to its low P/E ratio of 11, strong growth potential indicated by a PEG ratio of 0.16, and favorable EV to EBITDA ratio of 11.44, despite a year-to-date return of -29.85%.

As of 17 October 2025, the valuation grade for Avantor, Inc. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than the industry average, and a PEG ratio of 0.16, suggesting strong growth potential relative to its price. Additionally, the EV to EBITDA ratio stands at 11.44, which further supports the attractive valuation.<BR><BR>In comparison to its peers, Avantor's P/E ratio of 11.82 is notably lower than Westlake Corp.'s 82.20 and Albemarle Corp.'s -101.94, while NewMarket Corp. has a P/E of 16.30, indicating that Avantor is trading at a discount relative to some competitors. Despite recent underperformance, with a year-to-date return of -29.85% compared to the S&P 500's 13.30%, the current valuation metrics suggest that Avantor may present a compelling investment opportunity moving forward.

Read More

Is Avantor, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Avantor, Inc. shows a neutral technical trend with mixed signals, mildly bullish weekly MACD, bearish monthly MACD, and has outperformed the S&P 500 recently but underperformed year-to-date.

As of 24 October 2025, the technical trend for Avantor, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The RSI shows no signal on the weekly timeframe but is bullish on the monthly. Bollinger Bands indicate a bullish stance weekly but mildly bearish monthly. Moving averages are mildly bearish on the daily timeframe. Dow Theory and OBV both suggest a mildly bullish outlook on the weekly and monthly charts.<BR><BR>In terms of performance, Avantor has outperformed the S&P 500 over the past week and month, with returns of 4.19% and 28.23% respectively, but has significantly underperformed over longer periods, including a year-to-date return of -26.91% compared to the S&P 500's 15.47%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 9.33%

  • The company has been able to generate a Return on Capital Employed (avg) of 9.33% signifying low profitability per unit of total capital (equity and debt)
2

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.33%

3

Risky -

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 8,951 Million (Small Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.60

stock-summary
Return on Equity

12.05%

stock-summary
Price to Book

1.42

Revenue and Profits:
Net Sales:
1,683 Million
(Quarterly Results - Jun 2025)
Net Profit:
65 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.47%
0%
-15.47%
6 Months
-16.23%
0%
-16.23%
1 Year
-47.38%
0%
-47.38%
2 Years
-47.99%
0%
-47.99%
3 Years
-50.97%
0%
-50.97%
4 Years
-70.86%
0%
-70.86%
5 Years
-58.93%
0%
-58.93%

Avantor, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.04%
EBIT Growth (5y)
0.82%
EBIT to Interest (avg)
3.33
Debt to EBITDA (avg)
3.89
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.65
Tax Ratio
16.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
9.33%
ROE (avg)
14.11%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.46
EV to EBIT
18.02
EV to EBITDA
11.44
EV to Capital Employed
1.28
EV to Sales
1.90
PEG Ratio
0.16
Dividend Yield
NA
ROCE (Latest)
7.12%
ROE (Latest)
12.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 125 Schemes (58.97%)

Foreign Institutions

Held by 290 Foreign Institutions (28.13%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 6.45% vs -6.24% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.31% vs -87.11% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,683.40",
          "val2": "1,581.40",
          "chgp": "6.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "252.90",
          "val2": "251.50",
          "chgp": "0.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "56.60",
          "val2": "53.40",
          "chgp": "5.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.30",
          "val2": "-19.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.70",
          "val2": "64.50",
          "chgp": "0.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.20%",
          "val2": "96.00%",
          "chgp": "-0.68%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.64% vs -7.26% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 121.58% vs -53.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,783.60",
          "val2": "6,967.20",
          "chgp": "-2.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,135.70",
          "val2": "1,299.00",
          "chgp": "-12.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "328.30",
          "val2": "315.50",
          "chgp": "4.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-90.20",
          "val2": "-194.50",
          "chgp": "53.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "711.50",
          "val2": "321.10",
          "chgp": "121.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "107.60%",
          "val2": "128.70%",
          "chgp": "-2.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,683.40
1,581.40
6.45%
Operating Profit (PBDIT) excl Other Income
252.90
251.50
0.56%
Interest
56.60
53.40
5.99%
Exceptional Items
-19.30
-19.30
Consolidate Net Profit
64.70
64.50
0.31%
Operating Profit Margin (Excl OI)
89.20%
96.00%
-0.68%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 6.45% vs -6.24% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 0.31% vs -87.11% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6,783.60
6,967.20
-2.64%
Operating Profit (PBDIT) excl Other Income
1,135.70
1,299.00
-12.57%
Interest
328.30
315.50
4.06%
Exceptional Items
-90.20
-194.50
53.62%
Consolidate Net Profit
711.50
321.10
121.58%
Operating Profit Margin (Excl OI)
107.60%
128.70%
-2.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.64% vs -7.26% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 121.58% vs -53.23% in Dec 2023

stock-summaryCompany CV
About Avantor, Inc. stock-summary
stock-summary
Avantor, Inc.
Specialty Chemicals
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Company Coordinates stock-summary
Company Details
Building One, 100 W Matsonford Rd Ste 200 RADNOR PA : 19087
Registrar Details